LifeStance Health Group, Inc.
NASDAQ Global SelectRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- LifeStance Health Group, Inc. (LFST) provides outpatient mental health services to children, adolescents, adults, and geriatrics across the United States through a network of approximately 550 centers in 33 states; core offerings include psychiatric evaluations and treatment, psychological and neuropsychological testing, individual, family, and group therapy, psychotherapy, medication management, children and adolescent services, women's services, testing and evaluation, specialty treatments such as TMS and ketamine therapies, and addiction treatment, delivered via hybrid in-person and telehealth platforms treating conditions including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. Founded in 2017 and headquartered in Scottsdale, Arizona, the company operates a single reportable segment focused on mental health services, accepts over 300 insurances, and employs approximately 7,500 to 8,000 clinicians. Recent developments include a partnership with Calm Health announced in October 2025 to streamline access to licensed mental health clinicians for app users, a $100,000 grant and year-long collaboration with the American Foundation for Suicide Prevention in September 2025 supported by employee donation matching, completion of a $390 million senior secured credit facilities refinancing in October 2025 to replace prior private credit structures, rebranding of local practices such as Child & Family to the unified LifeStance Health name, plans for 20 to 25 new center openings by end-2025, addition of 288 net new clinicians in Q3 2025 for an 11% increase to 7,996 total, achievement of a second consecutive quarter of positive net income and Adjusted EBITDA margins of 11% in Q3 2025, and signals of disciplined mergers and acquisitions including potential tuck-in deals, digital therapeutics, and specialty services for 2025 and beyond following efficiency improvements and free cash flow positivity.
Wall Street Analysts Predict a 37.26% Upside in LifeStance Health (LFST): Here's What You Should Know
Bears are Losing Control Over LifeStance Health (LFST), Here's Why It's a 'Buy' Now
LifeStance Health Group, Inc. (LFST) Presents at Bank of America Global Healthcare Conference 2026 Prepared Remarks Transcript
Earnings Estimates Rising for LifeStance Health (LFST): Will It Gain?
LifeStance Health Group (LFST) is a Great Momentum Stock: Should You Buy?
Wall Street Analysts See a 31.02% Upside in LifeStance Health (LFST): Can the Stock Really Move This High?
LifeStance Health Group Q1 Earnings Call Highlights
LifeStance Health Group Announces Pricing of Secondary Public Offering
LifeStance Health Group Announces Pricing of Secondary Public Offering
Why LifeStance Health Group Zoomed 20% Higher Today
LifeStance Health Group Announces Launch of Secondary Public Offering
LifeStance Health Group, Inc. (LFST) Q1 2026 Earnings Call Transcript
LifeStance Reports First Quarter 2026 Results
LifeStance to Present at Upcoming Investor Conferences
A LifeStance Health Insider Sold Nearly 70,000 Shares. Here's What That Means for Investors.
New Strong Buy Stocks for April 28th
Chemed (NYSE:CHE) & LifeStance Health Group (NASDAQ:LFST) Financial Comparison
LifeStance Health Group, Inc. (NASDAQ:LFST) Receives Consensus Rating of “Moderate Buy” from Brokerages
LifeStance Publishes Outcomes Data Validating the Benefit of Mental Health Treatment at Scale
Chemed (NYSE:CHE) vs. LifeStance Health Group (NASDAQ:LFST) Financial Comparison